Evaluation of Microhematuria: A Risk-based Approach - Frankly Speaking Ep 199
Nov 23, 2020•14 min•Season 1Ep. 1
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-199
Overview: Microhematuria is a common finding. It is usually benign, but it needs proper evaluation since it may also be a sign of malignancy. A risk-based approach can avoid unnecessary testing, while still identifying those patients with malignancy. Recent American Urological Association (AUA) guidelines use a validated risk-based approach.
Guest: Alan Ehrlich, MD
Music Credit: Richard Onorato
For the best experience, listen in Metacast app for iOS or Android